Cargando…
Economic burden of moderate to severe irritable bowel syndrome with constipation in six European countries
BACKGROUND: Irritable bowel syndrome with predominant constipation (IBS-C) is a complex disorder with gastrointestinal and nervous system components. The study aim was to assess the economic burden of moderate to severe IBS-C in six European countries (France, Germany, Italy, Spain, Sweden and the U...
Autores principales: | Tack, Jan, Stanghellini, Vincenzo, Mearin, Fermín, Yiannakou, Yan, Layer, Peter, Coffin, Benoit, Simren, Magnus, Mackinnon, Jonathan, Wiseman, Gwen, Marciniak, Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505116/ https://www.ncbi.nlm.nih.gov/pubmed/31064345 http://dx.doi.org/10.1186/s12876-019-0985-1 |
Ejemplares similares
-
Review article: linaclotide for the management of irritable bowel syndrome with constipation
por: Layer, P, et al.
Publicado: (2014) -
Optimizing the Use of Linaclotide in Patients with Constipation-Predominant Irritable Bowel Syndrome: An Expert Consensus Report
por: Rey, Enrique, et al.
Publicado: (2017) -
Tegaserod in the treatment of irritable bowel syndrome (IBS) with constipation as the prime symptom
por: Layer, Peter, et al.
Publicado: (2007) -
Irritable Bowel Syndrome
por: Farup, Per G., et al.
Publicado: (2012) -
UK clinical experience up to 52 weeks with linaclotide for irritable bowel syndrome with constipation
por: Yiannakou, Yan, et al.
Publicado: (2018)